These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 13046543)

  • 1. [Agranulocytosis due to diparcol].
    DE HAAS G
    Ned Tijdschr Geneeskd; 1952 Dec; 96(49):3079-80. PubMed ID: 13046543
    [No Abstract]   [Full Text] [Related]  

  • 2. Agranulocytosis during treatment with diethazine hydrochloride.
    HELLER GC; SIME DA
    Lancet; 1952 Jan; 1(6700):192-3. PubMed ID: 14889809
    [No Abstract]   [Full Text] [Related]  

  • 3. [Agranulocytosis following administration of phenothiazine derivatives].
    HIOB J; HIPPIUS H
    Arztl Wochensch; 1955 Oct; 10(40):924-5. PubMed ID: 13268287
    [No Abstract]   [Full Text] [Related]  

  • 4. Agranulocytosis caused by phenothiazine derivatives.
    KORST DR
    J Am Med Assoc; 1959 Aug; 170(17):2076-81. PubMed ID: 13672804
    [No Abstract]   [Full Text] [Related]  

  • 5. Lysivane in the treatment of Parkinsonism.
    GILLHESPY RO
    Edinb Med J; 1953 Aug; 60(8):365-70. PubMed ID: 13083580
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic diagrams].
    SEGARD M; SIGURET G
    Hopital; 1953 Mar; 41(620):76-9. PubMed ID: 13068925
    [No Abstract]   [Full Text] [Related]  

  • 7. Parsidol in the treatment of parkinsonism.
    ZIEGLER DK; TORRES F
    Neurology; 1955 Mar; 5(3):197-200. PubMed ID: 14356348
    [No Abstract]   [Full Text] [Related]  

  • 8. Parsidol in the treatment of Parkinson's syndrome.
    SOBUE I; IVES ER
    Bull Los Angel Neuro Soc; 1956 Jun; 21(2):80-3. PubMed ID: 13329559
    [No Abstract]   [Full Text] [Related]  

  • 9. [Agranulocytosis after therapy with phenothiazine derivatives. A case report].
    KROGH I; STUBSGAARD O
    Ugeskr Laeger; 1960 Jun; 122():860-1. PubMed ID: 13754454
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trials of transergan in the parkinsonian syndrome.
    ELIASSON S; TEJNING S
    Acta Med Scand; 1956 Jun; 154(5):375-9. PubMed ID: 13326279
    [No Abstract]   [Full Text] [Related]  

  • 11. Agranulocytosis following therapy with phenothiazine derivatives.
    EMMERSON BT; STEINBECK AW
    Med J Aust; 1959 Nov; 46(2)():682-4. PubMed ID: 13820201
    [No Abstract]   [Full Text] [Related]  

  • 12. Fatal agranulocytosis during treatment with pacatal.
    FELDMAN PE; BERTONE J; PANTHEL H
    Am J Psychiatry; 1957 Mar; 113(9):842-3. PubMed ID: 13402978
    [No Abstract]   [Full Text] [Related]  

  • 13. Agranulocytosis during treatment with methylpromazine.
    FELDMAN PE; STATMAN J
    Am J Psychiatry; 1957 Nov; 114(5):464-5. PubMed ID: 13470125
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of agranulocytosis following sparine administration.
    REINHART MJ; SILVERSTEIN BS; CROSS TN
    Am J Psychiatry; 1957 Nov; 114(5):462-3. PubMed ID: 13470123
    [No Abstract]   [Full Text] [Related]  

  • 15. Agranulocytosis during treatment with pacatal.
    BIEZANEK A; GORE CP
    Lancet; 1956 Nov; 271(6952):1081. PubMed ID: 13377680
    [No Abstract]   [Full Text] [Related]  

  • 16. Fatal agranulocytosis due to triflupromazine hydrochloride.
    AYD FJ
    Am J Psychiatry; 1958 Apr; 114(10):940. PubMed ID: 13508933
    [No Abstract]   [Full Text] [Related]  

  • 17. Fatal agranulocytosis occurring during promazine (sparine) therapy.
    SOLOMON JD; WOODWARD DJ
    J Am Med Assoc; 1956 Dec; 162(14):1308-9. PubMed ID: 13366748
    [No Abstract]   [Full Text] [Related]  

  • 18. Fatal agranulocytosis due to promazine hydrochloride.
    EARLE BV
    Lancet; 1957 Nov; 273(7002):925-6. PubMed ID: 13482248
    [No Abstract]   [Full Text] [Related]  

  • 19. Agranulocytosis associated with promazine administration: report of three cases.
    GLASER GL; ADAMS DA
    Ann Intern Med; 1958 Feb; 48(2):372-9. PubMed ID: 13509542
    [No Abstract]   [Full Text] [Related]  

  • 20. Parkinsonism: preliminary report on two new antiparkinsonian agents.
    BERRIS H
    J Lancet; 1954 Jul; 74(7):245-6; passim. PubMed ID: 13221950
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.